ZIOPHARM Oncology, Inc. (ZIOP) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts ZIOP Hot Sheet
Join SI Premium – FREE
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reported Q2 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
